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ABSTRACT 
Mycobacterium tuberculosis encodes only a single type II topoisomerase, gyrase. As a result, this 
enzyme likely carries out the cellular functions normally performed by canonical gyrase and 
topoisomerase IV, both in front of and behind the replication fork. In addition, it is the sole target for 
quinolone antibacterials in this species. Because quinolone-induced DNA strand breaks generated on 
positively supercoiled DNA ahead of replication forks and transcription complexes are most likely to 
result in permanent genomic damage, the actions of M. tuberculosis gyrase on positively supercoiled 
DNA were investigated. Results indicate that the enzyme acts rapidly on overwound DNA and 
removes positive supercoils much faster than it introduces negative supercoils into relaxed DNA. 
Canonical gyrase and topoisomerase IV distinguish supercoil handedness differently during the DNA 
cleavage reaction: while gyrase maintains lower levels of cleavage complexes on overwound DNA, 
topoisomerase IV maintains similar levels of cleavage complexes on both over- and underwound 
substrates. M. tuberculosis gyrase maintained lower levels of cleavage complexes on positively 
supercoiled DNA in the absence and presence of quinolone-based drugs. By retaining this important 
feature of canonical gyrase, the dual function M. tuberculosis type II enzyme remains a safe enzyme to 
act in front of replication forks and transcription complexes. Finally, the N-terminal gate region of the 
enzyme appears to be necessary to distinguish supercoil handedness during DNA cleavage, suggesting 
that the capture of the transport segment may influence how gyrase maintains cleavage complexes on 
substrates with different topological states.  
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INTRODUCTION 
The vast majority of bacterial species encode two type II topoisomerases, topoisomerase IV and 
gyrase.
1-4
 These enzymes function as heterotetramers (GrlA2GrlB2 and ParC2ParE2 for topoisomerase 
IV in Gram-positive and Gram-negative species, respectively, and GyrA2GyrB2 for gyrase) and display 
sequence homology.
1-4
 Both enzymes regulate the topological state of DNA by creating a transient 
double-stranded break in one segment of DNA (the gate- or G-segment) and passing a second intact 
segment (the transport- or T-segment) through the break.
2,5-7
 To maintain genomic integrity during this 
process, topoisomerase IV and gyrase covalently attach to the 5’-terminus of each DNA strand.
2,5-7
 
This “cleavage complex” is a hallmark of enzyme activity.
8
 
 Despite this shared catalytic mechanism, differences in the C-terminal domains of GrlA/ParC and 
GyrA confer topoisomerase IV and gyrase with a unique array of catalytic activities.
3
 The C-terminal 
domain of GrlA/ParC allows topoisomerase IV to interact with distal DNA segments, which permits it 
to capture existing intra- or intermolecular DNA crossovers.
1,4
 This property confers the enzyme with 
the ability to relax (i.e., remove) positive or negative DNA supercoils. It also allows the enzyme to 
remove DNA knots and tangles in a highly efficient manner.
1,3,4
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 In contrast, the C-terminal domain of GyrA 
wraps DNA, inducing a positive supercoil 
between the G- and T-segments.
1,4,9-14
 Because 
these captured DNA segments are proximal to 
one another,
1,4,15
 gyrase greatly favors the 
catalysis of intramolecular strand passage 
reactions. As a result, the enzyme can efficiently 
alter superhelical density but is very poor at 
removing knots and tangles.
1,4,15,16
 Furthermore, 
because gyrase acts on the induced positive 
crossover, it carries out a unidirectional reaction 
in the presence of ATP in which it always 
decreases the DNA linking number.
1,4,17,18
 This 
allows the enzyme to remove positive, but not 
negative, supercoils and to reduce the linking 
number beyond that of relaxed DNA. Thus, 
among all known topoisomerases, gyrase is the 
only enzyme able to negatively supercoil DNA.
3,5
 
 As a result of the differences described 
above, gyrase and topoisomerase IV play distinct roles during DNA replication and transcription 
(Figure 1).
1,3,19-25
 Gyrase removes the positive supercoils that accumulate ahead of replication forks 
and goes on to restore the negative superhelicity of the genome. Although topoisomerase IV can also 
relax positive supercoils, its primary function is to remove the precatenanes/catenanes that are formed 
behind replication forks, which allows chromosomes to be segregated appropriately.  
Figure 1. Cellular functions of bacterial 
topoisomerases. Gyrase removes positively supercoiled 
DNA ahead of transcription (top) and replication 
(bottom) complexes and in conjunction with 
topoisomerase I, also maintains the negative 
superhelicity of the genome.
1,3,19-25
 Topoisomerase IV 
can remove positive supercoils, but primarily acts 
behind the replication fork to resolve precatenanes and 
unlink daughter chromosomes. Topoisomerase I acts to 
remove negative supercoils that are generated behind 
transcription complexes. In species that encode gyrase 
as the only type II topoisomerase, such as M. 
tuberculosis, the enzyme likely carries out the 
functions of both gyrase and topoisomerase IV and acts 
ahead of transcription complexes and ahead of and 
behind replication forks.
25
 
 
(+) Supercoils
Gyrase
(+) Supercoils
Gyrase
Transcription Machinery 
(–) Supercoils (+) Supercoils 
se Topoisomerase I 
Precatenanes (+) Supercoils
Topoisomerase IV Gyrase
Replication Machinery
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 5
 Beyond their essential cellular functions, both bacterial type II topoisomerases are targe 
ts for quinolone antibacterials, which kill cells by stabilizing cleavage complexes.
2,7,26,27
 As replication 
forks, transcription complexes, or other DNA tracking systems encounter these protein-bound DNA 
roadblocks, transient cleavage complexes are converted to non-ligatable DNA breaks that induce DNA 
damage response pathways. When these pathways are overwhelmed, the DNA breaks result in cell 
death. Because quinolone-stabilized cleavage complexes formed ahead of moving forks and 
transcription complexes are most likely to be converted to non-ligatable strand breaks, cleavage 
complexes stabilized on positively supercoiled DNA are the most dangerous for the cell. A previous 
study on type II topoisomerases from Bacillus anthracis and Escherichia coli found that gyrase 
maintains lower levels of cleavage complexes with positively (as compared to negatively) supercoiled 
DNA,
28
 making it a safer enzyme to function ahead of replication forks and transcription complexes.
25
 
Conversely, topoisomerase IV, which acts behind replication forks, reportedly maintains levels of 
cleavage complexes on positively supercoiled DNA that are similar to
28
 or higher than
29
 those 
generated on negatively supercoiled molecules. 
 In contrast to the great majority of bacteria, a few species encode only a single type II 
topoisomerase II, gyrase. Among these are several disease-causing organisms, including Treponema 
pallidum (syphilis),
30
 Helicobacter pylori (stomach and intestinal ulcers),
31
 Campylobacter jejuni 
(gastroenteritis),
32
 Mycobacterium leprae (leprosy),
33
 and Mycobacterium tuberculosis (tuberculosis).
34
 
Worldwide, tuberculosis is one of the top ten causes of death and ranks above HIV/AIDS as the 
leading cause of death due to an infectious disease.
35
 Because gyrase is the only type II topoisomerase 
in M. tuberculosis, it must carry out the activities of both gyrase and topoisomerase IV.
25
 Therefore, it 
is functionally distinct from the “canonical” gyrases found in most species (i.e., species that encode 
both gyrase and topoisomerase IV).
36,37
 Furthermore, M. tuberculosis gyrase is the sole target for 
quinolones in this species. Although the standard treatment regimen for tuberculosis does not typically 
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 6
include quinolones, the fourth-generation quinolone antibacterials moxifloxacin and gatifloxacin are 
critical drugs for treating patients who have multidrug-resistant tuberculosis or are intolerant of first-
line therapies.
35
 
 Because M. tuberculosis gyrase, a “dual function” gyrase/topoisomerase IV enzyme,
36,37
 is the sole 
type II topoisomerase and quinolone target in the cell and because quinolone-induced cleavage 
complexes formed on positively supercoiled DNA ahead of replication forks and transcription 
complexes are the most dangerous for the cell, we investigated the actions of this enzyme on 
overwound DNA. Results indicate that M. tuberculosis gyrase removes positive supercoils much more 
rapidly than it introduces negative supercoils into relaxed DNA. Like “canonical” gyrase, and in 
contrast to topoisomerase IV, M. tuberculosis gyrase maintains lower levels of cleavage complexes on 
positively supercoiled DNA in the absence and presence of quinolone-based drugs. By retaining this 
important feature of canonical gyrase, the dual function M. tuberculosis type II enzyme remains a safe 
enzyme to act in front of replication forks and transcription complexes. Finally, the ability of gyrase to 
distinguish supercoil handedness during DNA cleavage is not dependent on elements in the C-terminal 
domain of GyrA but appears to require the N-terminal portion of GyrB.  
MATERIALS AND METHODS 
Enzymes and Materials. Full-length M. tuberculosis gyrase subunits (GyrA and GyrB) were 
expressed and purified as described previously.
38
 A C-terminally deleted GyrA mutant (GyrA
∆CTD
, 
residues 2-500 of GyrA) was cloned into a pET28b derivative that added an N-terminal tobacco etch 
virus protease (TEV)-cleavable 6xHis tag. The catalytic core (a fusion of residues 426-675 of GyrB 
with residues 2-500 of GyrA) was cloned into a pET28b derivative that added N-terminal TEV-
cleavable 6xHis and maltose binding protein tags, as described previously.
39
 Each construct was 
expressed and purified as described for the wild-type subunits,
38
 except that cells carrying the catalytic 
core construct were grown in medium containing 100 µg/mL ampicillin. 
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 7
Negatively supercoiled pBR322 DNA was prepared from E. coli using a Plasmid Mega Kit 
(Qiagen) as described by the manufacturer. Positively supercoiled pBR322 DNA was prepared by 
treating negatively supercoiled molecules with recombinant Archaeoglobus fulgidus reverse 
gyrase.
40,41
 The number of positive supercoils induced by this process was comparable to the number 
of negative supercoils in the original pBR322 preparations.
40
 In all experiments that compared 
negatively with positively supercoiled DNA, the negatively supercoiled plasmid preparations were 
processed identically to the positively supercoiled molecules except that reaction mixtures did not 
contain reverse gyrase. Relaxed pBR322 plasmid DNA was generated by treating negatively 
supercoiled pBR322 with calf thymus topoisomerase I (Invitrogen) and purified as described 
previously.
42
 
Ciprofloxacin was obtained from LKT Laboratories, stored at 4 °C as a 40 mM stock solution in 
0.1 N NaOH, and diluted fivefold with 10 mM Tris-HCl (pH 7.9) immediately prior to use. 
Moxifloxacin was obtained from LKT Laboratories, and levofloxacin was obtained from Sigma 
Aldrich. Both drugs were stored at 4 °C as 20 mM stock solutions in 100% DMSO. 8-Methyl-
moxifloxacin (1-cyclopropyl-6-fluoro-1,4-dihydro-8-methyl-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-
b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid) and 3’-(AM)P-dione (3-amino-7-[(3S)-3-
(aminomethyl)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-8-methyl-2,4(1H,3H)-quinazolinedione) were 
generous gifts from Dr. Robert J. Kerns (University of Iowa). These compounds were synthesized as 
reported previously
43,44
 and were stored at 4 °C as 20 mM stock solutions in DMSO. CP-115,953 was 
the generous gift of Thomas D. Gootz and Paul R. McGuirk (Pfizer Global Research), was stored at -
20 °C as a 40 mM solution in 0.1 N NaOH, and was diluted five-fold with 10 mM Tris-HCl (pH 7.9) 
immediately prior to use. All other chemicals were analytical reagent grade. 
 DNA Supercoiling. DNA supercoiling assays were based on previously published protocols.
38,43
 
Assays contained 50 nM gyrase (2:1 GyrA:GyrB ratio), 5 nM positively supercoiled or relaxed 
Page 7 of 25
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 8
pBR322, and 1.5 mM ATP in 20 µL of 10 mM Tris-HCl (pH 7.5), 40 mM KCl, 6 mM MgCl2, 2 mM 
DTT, 0.1 mg/mL BSA, and 10 % glycerol. Reactions were incubated at 37 °C for various times and 
stopped by the addition of 3 µL of a mixture of 0.77% SDS and 77.5 mM Na2EDTA. Samples were 
mixed with 2 µL of Agarose Loading Dye [60% sucrose in 10 mM Tris-HCl (pH 7.9), 0.5% 
bromophenol blue, and 0.5% xylene cyanol FF] and subjected to electrophoresis in 1% agarose gels in 
TBE [100 mM Tris-borate (pH 8.3) and 2 mM EDTA]. Gels were stained with 1 µg/mL ethidium 
bromide for 30 min. DNA bands were visualized with medium-range ultraviolet light on an Alpha 
Innotech digital imaging system. 
 Alternatively, reaction products were analyzed by two-dimensional gel electrophoresis as described 
previously.
40
 The first dimension was run for 2 h as described in the preceding paragraph. The gel was 
then soaked in TBE containing 4.5 µg/mL chloroquine for 2 h with gentle shaking followed by 
electrophoresis in the orthogonal direction (90° clockwise) for 2 h in fresh TBE containing 4.5 µg/mL 
chloroquine. Gels were stained and DNA bands were visualized as described above. 
 Gyrase-DNA Binding.  DNA binding by M. tuberculosis gyrase was monitored by an 
electrophoretic mobility shift assay.
45
 Reactions contained 0–1000 nM gyrase (3:2 GyrA:GyrB ratio) 
and 10 nM positively or negatively supercoiled pBR322 in a total volume of 20 µL of 10 mM Tris-HCl 
(pH 7.5), 40 mM KCl, 0.1 mg/mL BSA, and 10% glycerol. Reactions were incubated at 37 °C for 10 
min. Samples were mixed with 2 µL of Agarose Loading Dye and subjected to electrophoresis in 1% 
agarose gels in TAE [40 mM Tris-acetate (pH 8.3) and 2 mM Na2EDTA]. Gels were stained and DNA 
bands were visualized as described above. 
 DNA Cleavage. DNA cleavage reactions were based on the procedure of Aldred et al.
43
 Reactions 
contained 100 nM wild-type or GyrA
∆CTD
 gyrase (3:2 GyrA:GyrB ratio) or 100 nM catalytic core and 
10 nM positively supercoiled, negatively supercoiled, or relaxed pBR322 in a total volume of 20 µL of 
10 mM Tris-HCl (pH 7.5), 40 mM KCl, 6 mM MgCl2, 0.1 mg/mL BSA, and 10 % glycerol. Reactions 
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 9
were incubated at 37 °C for 10 min. Enzyme-DNA cleavage complexes were trapped by adding 2 µL 
of 5% SDS followed by 2 µL of 250 mM Na2EDTA and 2 µL of 0.8 mg/mL Proteinase K. Reaction 
mixtures were incubated at 45 °C for 30 min to digest the enzyme. Samples were mixed with 2 µL of 
Agarose Loading Dye and incubated at 45 °C for 2 min before loading on gels. Reaction products were 
subjected to electrophoresis in 1% agarose gels in TAE containing 0.5 µg/mL ethidium bromide 
(except for reactions containing relaxed DNA, which were run in gels without EtBr and stained with 1 
µg/mL EtBr after electrophoresis) and visualized as described above. DNA cleavage was monitored by 
the conversion of supercoiled plasmid to linear molecules and quantified by comparison to a control 
reaction in which an equal mass of DNA was digested by EcoRI (New England BioLabs).  
RESULTS AND DISCUSSION 
M. tuberculosis Gyrase Relaxes Positive DNA Supercoils More Rapidly than It Introduces 
Negative Supercoils. The sole type II topoisomerase in M. tuberculosis is defined as a gyrase based on 
its ability to introduce negative supercoils into relaxed DNA.
36
 However, the enzyme displays a higher 
decatenation activity than observed in a canonical gyrase and is therefore a dual function 
gyrase/topoisomerase IV enzyme.
36,37
 The ability of this enzyme to supercoil relaxed DNA is well 
documented,
36-38,46
 but no studies have investigated its actions on positively supercoiled DNA. To 
determine how this dual function gyrase/topoisomerase IV type II enzyme interacts with overwound 
DNA, we assessed the ability of M. tuberculosis gyrase to relax a positively supercoiled plasmid and 
subsequently convert it to a negatively supercoiled molecule. Enzyme activity was monitored over 45 
min in order to observe both the removal of positive supercoils (the relaxation reaction) and the 
introduction of negative supercoils (the supercoiling reaction) within the same assay.  
As shown in Figure 2 (top), gyrase rapidly relaxed the overwound DNA and subsequently 
introduced negative supercoils much more slowly. To further investigate the removal of positive 
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supercoils, we monitored relaxation over a shorter 
time course (Figure 2, middle). All of the positive 
supercoils appear to be removed by ~2 min. 
Conversely, the conversion of relaxed plasmid to 
negatively supercoiled DNA took 30–45 min. A 
similar time course for DNA supercoiling was 
observed whether the initial substrate was 
positively supercoiled (Figure 2, top) or relaxed 
(Figure 2, bottom), highlighting the distinction 
between rates of relaxation and supercoiling. This 
pattern of activity is similar to that observed for B. 
anthracis and E. coli gyrase.
28
 Therefore, like 
these canonical gyrases, the dual function type II 
enzyme from M. tuberculosis functions differently 
on positively supercoiled and relaxed DNA. 
To determine the handedness of the 
topoisomers in the later stages of the relaxation reaction (Figure 2, middle), reaction products were 
analyzed by two-dimensional gel electrophoresis. As shown in Figure 3, all positive supercoils were 
removed by 2 min, and negatively supercoiled DNA started to appear between 2 and 3 min. This result 
confirms the conclusion that the relaxation of positive supercoils occurs at least 20-fold faster than the 
introduction of negative supercoils. However, under the conditions employed, both of these processes 
appear to take place in a distributive manner with the bulk of the DNA moving synchronously through 
all of the intermediate topoisomers between the positively supercoiled substrate and the fully 
negatively supercoiled product.  
Figure 2. Gyrase removes positive supercoils more 
rapidly than it introduces negative supercoils into 
relaxed DNA. Top: Gyrase activity on positively 
supercoiled DNA. A time course is shown for the 
relaxation of positive supercoils followed by the 
introduction of negative supercoils. Positively 
supercoiled [(+)SC] and negatively supercoiled 
[(-)SC] standards are shown. Middle: Expanded time 
course for the relaxation of (+)SC DNA by gyrase. 
Bottom: Time course for the introduction of negative 
supercoils into relaxed DNA (Rel) by gyrase. Gel 
images are representative of at least three 
independent experiments. 
(+)SC 0 1 2 3 4 5 6 8 10 15 20 30 45 (-)SC
Time (min)
Nicked
(+)SC
(-)SC
Rel 0 1 2 3 4 5 6 8 10 15 20 30 45 (-)SC
Time (min)
Nicked
(-)SC
Rel
(+)SC
Nicked
(+)SC
(-)SC
0 20 40 60 80 100 120 140 160 180 200 220 240 (-)SC
Time (s)
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 Gyrase Has a Higher Affinity for Positively Supercoiled than Negatively Supercoiled DNA.  A 
previous study found that E. coli gyrase displays an ~10-fold higher affinity for relaxed over 
negatively supercoiled DNA.
47
 However, binding interactions with positively supercoiled molecules 
have yet to be assessed for gyrase. Because M. tuberculosis gyrase carries out distributive reactions for 
both the removal of positive supercoils and the introduction of negative supercoils, we determined 
whether the differences in reaction rates reflect differences in enzyme affinity for positively and 
negatively supercoiled DNA. An electrophoretic mobility shift assay was employed to assess the 
relative affinities of gyrase for positively or negatively supercoiled molecules. As shown in Figure 4, 
gyrase induced much greater shifts with positively supercoiled DNA than negatively supercoiled 
molecules and did so at lower enzyme concentrations. The nicked DNA in these gels served as an 
Rel
(+)SC
(-)SC
Nicked
Control 1 min
2 min 3 min
Rel
(-)SC
Nicked
Rel
(+)SC
(-)SC
Nicked
Rel
(-)SC
Nicked
Figure 3. Two-dimensional gel analysis of gyrase 
activity on positively supercoiled DNA. The mobility 
of nicked, positively supercoiled [(+)SC], relaxed 
(Rel), and negatively supercoiled [(-)SC] DNA are 
indicated in a control gel (top left). DNA products 
generated after 1 min (top right), 2 min (bottom left), 
and 3 min (bottom right) reactions are shown. Gel 
images are representative of at least three 
independent experiments. 
 
0
0 100 200 400 600 800 1000
Enzyme (nM)
100 200 400 600 800 1000
Enzyme (nM)
Nicked
(+)SC
Nicked
(-)SC
Figure 4. Gyrase preferentially binds positively 
supercoiled DNA. The electrophoretic mobility shifts 
of positively supercoiled [(+)SC), top] and negatively 
supercoiled [(-)SC, bottom] DNA induced by 
increasing concentrations of gyrase are shown. 
Original positions of nicked, (+)SC, and (-)SC DNA 
are indicated. Gel images are representative of at least 
three independent experiments. 
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internal control for molecules that were not under torsional stress. In the presence of positively 
supercoiled DNA, gyrase did not substantially shift the nicked/relaxed molecules, suggesting that the 
enzyme has a significantly higher affinity for the positively supercoiled plasmid. In contrast, in 
incubations with negatively supercoiled DNA, gyrase preferentially shifted the nicked plasmid and 
altered its mobility to a much greater extent than it did with the negatively supercoiled molecules. 
Thus, gyrase appears to have a higher affinity for positively supercoiled DNA than negatively 
supercoiled DNA and has an intermediate affinity for DNA molecules that lack torsional stress. This 
pattern is consistent with positively supercoiled DNA being the preferred substrate for gyrase-
catalyzed DNA strand passage, with relaxed DNA as an intermediary product and negatively 
supercoiled DNA as the final reaction product.  
 Gyrase Maintains Lower Levels of Cleavage Complexes with Positively Supercoiled DNA. 
The cleavage complexes that are most dangerous for the cell are those that are formed on overwound 
DNA ahead of moving tracking systems. Previous studies indicate that gyrase and topoisomerase IV 
differ in their ability to recognize DNA geometry while they are cleaving the double helix.
28,29
 This 
specificity may be related to the position of each enzyme relative to replication forks and transcription 
complexes.
1,3,19-25
 Canonical gyrase, which functions ahead of these tracking systems, often works on 
overwound DNA and has the potential to create dangerous cleavage complexes. Consistent with this 
function, gyrase maintains lower levels of cleavage complexes on positively supercoiled DNA.
28
 In 
contrast, topoisomerase IV works primarily behind replication forks and is less likely to encounter 
moving DNA tracking systems. Thus, it does not distinguish between overwound and underwound 
DNA during cleavage (or actually maintains higher levels of cleavage complexes with positively 
supercoiled substrates).
28,29
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 As a dual function enzyme, M. tuberculosis 
gyrase must be able to work both ahead of and 
behind the replication fork and other DNA tracking 
systems and could conceivably distinguish supercoil 
handedness during DNA cleavage as a gyrase or as 
a topoisomerase IV. To address this issue, the 
ability of M. tuberculosis gyrase to cleave positively 
and negatively supercoiled DNA was determined. 
Like canonical gyrase,
28
 M. tuberculosis gyrase 
maintained ~3-fold lower levels of cleavage 
complexes on overwound compared to underwound 
DNA in the absence of drugs (Figure 5). This 
discrimination is despite the fact that the enzyme 
displays a higher affinity for positively supercoiled 
molecules and suggests that M. tuberculosis gyrase 
cycles through the DNA cleavage reaction more rapidly on positively supercoiled substrates.   
 Because quinolones stabilize cleavage complexes and are clinically important drugs for the 
treatment of tuberculosis, we also monitored cleavage complexes generated by gyrase in the presence 
of moxifloxacin (Figure 6). Similar to the results seen in the absence of drugs, gyrase maintained ~3-
fold lower levels of cleavage complexes on positively supercoiled molecules. Levels of cleavage 
complexes generated by the enzyme on relaxed DNA were between those generated on positively and 
negatively supercoiled plasmid. Gyrase also maintained the distinction between over-and underwound 
DNA in the presence of ciprofloxacin or levofloxacin, two other clinically relevant quinolones; CP-
115,953, a quinolone that displays high activity against both bacterial and eukaryotic type II 
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Figure 5. Gyrase maintains lower levels of cleavage 
complexes on positively supercoiled DNA in the 
absence of drugs.  Levels of cleavage complexes 
generated by varying concentrations of gyrase on 
positively supercoiled [(+)SC DNA, red] or 
negatively supercoiled [(-)SC DNA, blue] are shown. 
Error bars represent the standard deviations for at 
least three independent experiments. 
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topoisomerases;
48-51
 and two quinolone-derived drugs, 8-methyl-moxifloxacin and 3’-(AM)P-dione, 
which overcome quinolone resistance caused by mutations in M. tuberculosis gyrase
38,39
 (Figure 7). 
These results suggest that, although gyrase in M. tuberculosis has adapted to perform some of the 
functions of topoisomerase IV, it still retains the characteristics that make gyrase a safe enzyme to 
function ahead of replication forks and other DNA tracking systems such as RNA polymerase. 
 Recognition of Supercoil Geometry During Cleavage Is Not Dependent on the C-Terminal 
Domain of GyrA but Does Require the N-Terminal Portion of GyrB. A previous study with E. coli 
gyrase demonstrated that removal of the entire C-terminal domain (CTD) of GyrA converted gyrase to 
a “conventional” type II topoisomerase.
12
 The enzyme was no longer able to introduce negative 
supercoils into relaxed DNA but, like topoisomerase IV, gained the ability to relax negatively 
supercoiled DNA in the presence of ATP and exhibited a higher decatenation activity than the parent 
enzyme. However, the effects of this alteration on DNA cleavage have not been examined. For human 
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Figure 6. Gyrase maintains lower levels of cleavage 
complexes on positively supercoiled DNA in the 
presence of moxifloxacin. Left: Levels of cleavage 
complexes generated by gyrase on positively 
supercoiled [(+)SC DNA, red], relaxed (Rel, green), 
or negatively supercoiled [(-)SC DNA, blue] in the 
presence of the quinolone moxifloxacin. Error bars 
represent the standard deviations for at least three 
independent experiments. Right: Representative gels 
of DNA cleavage induced by gyrase on negatively 
supercoiled [(-)SC, top], relaxed (Rel, middle), or 
positively supercoiled [(+)SC, bottom] DNA in the 
presence of moxifloxacin. DNA controls in the 
absence of enzyme (DC) and DNA digested by 
EcoRI (EcoRI) are shown. The positions of nicked, 
relaxed, linear, and supercoiled DNA are indicated. 
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Figure 7. Gyrase maintains lower levels of cleavage 
complexes on positively supercoiled DNA in the 
presence of ciprofloxacin, levofloxacin, and other 
quinolone-derived compounds. Left: Levels of 
cleavage complexes generated by gyrase on positively 
supercoiled [(+)SC DNA, red] or negatively 
supercoiled [(-)SC DNA, blue] in the presence of 
ciprofloxacin. Right: Levels of cleavage complexes 
generated by gyrase on positively supercoiled [(+)SC 
DNA, red] or negatively supercoiled [(-)SC DNA, 
blue] in the presence of levofloxacin (Levo, 100 µM), 
CP-115,953 (953, 100 µM), 8-methyl-moxifloxacin 
(Me-Moxi, 20 µM), and 3’-(AM)P-dione (Dione, 20 
µM). Error bars represent the standard deviations for 
at least three independent experiments. 
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topoisomerase IIα, removal of the CTD does not 
change the ability of the enzyme to discern 
supercoil handedness during cleavage.
52
 To 
determine the role of the CTD in DNA geometry 
recognition by a bacterial enzyme during cleavage, 
we monitored the ability of M. tuberculosis gyrase 
that contained wild-type GyrB and a mutant GyrA 
in which the CTD was deleted (GyrA
∆CTD
 gyrase, 
which contains residues 2-500 of GyrA) to cleave 
over- and underwound DNA substrates (Figure 8). 
GyrA
∆CTD
 gyrase still maintained lower levels of 
cleavage complexes with positively supercoiled 
DNA. Therefore, like the human enzyme, the ability of M. tuberculosis gyrase to distinguish supercoil 
handedness during the cleavage reaction does not rely on the CTD.  
 It is not obvious which portion of M. tuberculosis gyrase is responsible for the recognition of DNA 
geometry during cleavage. Although DNA scission occurs within the catalytic core of the enzyme 
(defined as residues 426-675 of GyrB and residues 2-500 of GyrA), the N-terminal gate region 
(residues 2-425 of GyrB) is crucial for capturing the T-segment.
53-55
 The N-terminal gate in eukaryotic 
type II topoisomerases is also important for capturing the T-segment
56
 and changes within this region 
have been shown to modulate rates of DNA cleavage.
57,58
 Therefore, this region on M. tuberculosis 
gyrase could have an important role in distinguishing supercoil handedness. Previous work with the 
catalytic core of human topoisomerase IIα showed that the N-terminal gate was not required for the 
recognition of supercoil geometry during cleavage.
56
 To determine if this was also the case for the 
bacterial type II topoisomerase, we evaluated the ability of the catalytic core of M. tuberculosis to 
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Figure 8. GyrA
∆CTD
 gyrase maintains lower levels of 
cleavage complexes on positively supercoiled DNA. 
Left: Levels of cleavage complexes generated by 
varying concentrations of GyrA
∆CTD
 gyrase on 
positively supercoiled [(+)SC, red] or negatively 
supercoiled [(-)SC, blue] DNA in the absence of 
quinolones. Right: Levels of cleavage complexes 
generated by GyrA
∆CTD
 gyrase on positively 
supercoiled [(+)SC, red] or negatively supercoiled 
[(-)SC, blue] DNA in the presence of moxifloxacin. 
Error bars represent the standard deviations for at 
least three independent experiments. 
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cleave positively and negatively supercoiled DNA 
(Figure 9). Unlike full-length or GyrA
∆CTD
 gyrase, 
the catalytic core did not distinguish between 
overwound and underwound DNA and maintained 
similar levels of cleavage complexes on both 
substrates in the absence or presence of 
moxifloxacin. Therefore, the ability of M. 
tuberculosis gyrase to recognize DNA geometry 
during cleavage appears to be embedded, at least in 
part, in the N-terminal region of the enzyme.  
 Conclusions. Gyrase from M. tuberculosis and 
other species encoding a single type II 
topoisomerase must carry out the functions usually associated with topoisomerase IV. Thus, gyrase 
from these species has a mix of characteristics from canonical gyrases (ability to induce negative 
supercoils into DNA) and topoisomerase IV (ability to decatenate DNA).
36,37
 Our results indicate that 
the dual function M. tuberculosis gyrase retains features of canonical gyrase that make it a safer 
enzyme to function ahead of moving DNA tracking systems. In particular, it is able to rapidly remove 
positive supercoils, while its introduction of negative supercoils occurs more slowly. Furthermore, it is 
able to distinguish between positively and negatively supercoiled DNA during the cleavage reaction 
and maintains significantly lower levels of cleavage complexes on overwound DNA. The N-terminal 
gate region of the enzyme is required to distinguish supercoil handedness, suggesting that the capture 
of the transport segment may influence how gyrase maintains cleavage complexes on substrates with 
different topological states. The involvement of the N-terminal region in geometry recognition also 
points to a mechanistic difference between M. tuberculosis gyrase and human topoisomerase IIα,
56
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Figure 9. The catalytic core of gyrase maintains 
similar levels of cleavage complexes on positively 
and negatively supercoiled DNA. Left: Levels of 
cleavage complexes generated by varying 
concentrations of the catalytic core on positively 
supercoiled [(+)SC, red] or negatively supercoiled 
[(-)SC, blue] DNA in the absence of quinolones. 
Right: Levels of cleavage complexes generated by the 
catalytic core on positively supercoiled [(+)SC, red] 
or negatively supercoiled [(-)SC, blue] DNA in the 
presence of moxifloxacin. Error bars represent the 
standard deviations for at least three independent 
experiments. 
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implying that bacterial and eukaryotic topoisomerases may utilize distinct methods for sensing the 
supercoil geometry of their substrates. 
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